Business Wire

Esri Joins the Overture Maps Foundation to Help Build Interoperable Open Map Data

6.2.2023 23:00:00 EET | Business Wire | Press release

Share

In an increasingly digital and automated world, geospatial data plays a critical role in understanding the physical environment and powering the next generation of location technologies. For geospatial developers and professionals, the ability to access reliable open map data is vital to understanding communities and building innovative services and solutions.

To support this demand, Esri, the global leader in location intelligence, has joined the Overture Maps Foundation—a collaboration founded by Amazon Web Services (AWS), Meta, Microsoft, and TomTom. Overture’s mission is to create reliable, easy-to-use, and interoperable open map data.

Historically, using open map sources posed challenges for geospatial developers and professionals. These include collecting comprehensive data from disparate sources, curating data of variable quality and currency, combining datasets with different structures, testing data for errors and inconsistencies, and enabling integration with other map products. These are challenges the Overture Maps Foundation seeks to overcome, building on the work of other open data projects such as OpenStreetMap.

"Ready access to geospatial information has fueled the innovation of many technologies and products, benefitting organizations and communities around the world," said Deane Kensok, Esri ArcGIS Content CTO. "Esri is committed to expanding access to ready-to-use map data and helping the global geospatial community who are building the next generation of location-based apps and solutions for tomorrow's challenges."

Members of Overture will provide data and technological contributions, combining their resources to create complete, accurate, and extensible real-world map data that is available under an open data license. As a member, Esri will help curate data from its extensive collection of community contributions assembled through its well-established Community Maps Program, which contributors have chosen to share as open data.

"Overture's mission to build the best possible open map data includes incorporating high-quality geospatial data from cities and local governments. As part of a worldwide database, data from those authoritative sources can support geospatial applications for billions of end users," said Jan Erik Solem, chairperson for the Overture Maps Foundation and engineering director of Maps at Meta. "Esri's long commitment to open data and supporting federal, state, and local government mapping efforts makes them a great addition.”

Esri will continue to both encourage and enable the sharing of open data by authoritative sources and to help integrate that data into the Overture ecosystem in various ways. This will benefit all users of Overture data, including government organizations and their constituents that will be able to access the Overture data through Esri’s ArcGIS software and other services.

“Esri has a long history of collecting and curating geospatial data from authoritative and community sources to enable a wide variety of use cases,” said Michael Kopenec, general manager for AWS Geospatial. “They have been a valued mapping partner of Amazon Location Service, and we are pleased to welcome Esri as a member of the Overture Maps Foundation, where they will bring their valuable experience to the project and accelerate delivery of high-quality mapping data to developers.”

To learn more about Esri’s role in the Overture Maps Foundation’s open data ecosystem, visit esri.com/arcgis-blog/products/arcgis-living-atlas/announcements/esri-joins-overture-maps-foundation/.

About Esri

Esri, the global market leader in geographic information system (GIS) software, location intelligence, and mapping, helps customers unlock the full potential of data to improve operational and business results. Founded in 1969 in Redlands, California, USA, Esri software is deployed in more than 350,000 organizations globally and in over 200,000 institutions in the Americas, Asia and the Pacific, Europe, Africa, and the Middle East, including Fortune 500 companies, government agencies, nonprofits, and universities. Esri has regional offices, international distributors, and partners providing local support in over 100 countries on six continents. With its pioneering commitment to geospatial information technology, Esri engineers the most innovative solutions for digital transformation, the Internet of Things (IoT), and advanced analytics. Visit us at esri.com.

Copyright © 2023 Esri. All rights reserved. Esri, the Esri globe logo, The Science of Where, esri.com, and @esri.com are trademarks, service marks, or registered marks of Esri in the United States, the European Community, or certain other jurisdictions. Other companies and products or services mentioned herein may be trademarks, service marks, or registered marks of their respective mark owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Jo Ann Pruchniewski
Public Relations, Esri
Mobile: 301-693-2643
Email: jpruchniewski@esri.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 14:00:00 EEST | Press release

Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early, subtle symptoms. Individuals in this stage, classified as CHR-P, represent a critical pr

SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend21.5.2026 13:30:00 EEST | Press release

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate receipt of the dividend. The Company has now extended that submission deadline to June 30, 2026. Shareholders and nominee brokers that have not yet submitted their instruction materials are reminded to do so on or before June 30, 2026 in order to facilitate payment of the dividend. If you have any questions regarding the process you need to un

Cranium AI and ISTARI Forge Global Alliance to Drive Enterprise AI Security and Governance21.5.2026 13:00:00 EEST | Press release

Cranium AI, the leading end-to-end AI Security and Governance platform, and ISTARI, a leading cyber resilience advisory firm, today announced a strategic partnership to provide global organizations with an end-to-end AI security & governance solution. As organizations accelerate AI adoption, they face a critical challenge: implementing actionable, operational AI governance while keeping pace with the speed of the AI landscape. This collaboration bridges that gap by merging Cranium’s cutting-edge AI security and governance platform with ISTARI’s deep advisory expertise in cyber risk and operating model design. Together, the firms provide a powerful, end-to-end solution for enterprises navigating the complexities of AI transformation. A Unified Vision for Sustainable AI Governance The partnership is built on a shared mission to move organizations beyond fragmented AI initiatives toward fully operationalized, secure, and governed programs. By combining Cranium’s platform automation with I

Cognite and ABB Collaborate to Integrate Agentic AI into Industrial Applications to Deliver Faster Workflows21.5.2026 13:00:00 EEST | Press release

Cognite, the leader in Industrial AI, today announced a collaboration with ABB to assess how advanced industrial AI and data capabilities can be integrated to solve key use cases in the energy sector. By adding an agentic layer to established industrial applications, including ABB Ability™ SafetyInsight™ and ABB Ability™ AlarmInsight™, using the Cognite Industrial AI and Data platform, the collaboration aims to enable "agent-to-agent" orchestration. Leading energy producer Aker BP has signed on as the first customer to implement this new generation of intelligent offerings as part of its strategy to further increase its current production efficiency of 96% and achieve a production growth target of 525,000 barrels of oil equivalent per day by 2028. Transforming Data into Actionable Business Value By breaking down traditional data silos and shifting to outcome-based software orchestration, the collaboration aims to deliver significant business value to ABB and Cognite customers, includin

BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts21.5.2026 13:00:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that more than 60 abstracts across hematologic malignancies and solid tumors have been accepted for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (May 29–June 2, Chicago) and the 2026 European Hematology Association (EHA) Congress (June 11–14, Stockholm). Continuing to raise the bar in CLL At ASCO and EHA 2026, BeOne will showcase its hematology leadership with data spanning foundational therapies and next-generation innovation across CLL, mantle cell lymphoma and other B-cell malignancies. The data emphasize impressive long-term outcomes, durability across patient populations, and a disciplined approach to advancing future regimens. Collectively, these data underscore BeOne’s strategy to lead in hematology science and patient impact by setting the standard today – while helping to shape the future of CLL. Amit Agarwal, M.D., Ph.D., Chief Medic

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye